Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a small update to page metadata/UI without changes to the trial details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, reflecting a minor adjustment to the study record metadata.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4 to reflect a new version of the page.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the page's content or formatting since the last version.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now displays an updated software revision tag, changing from v3.6.0 to v3.6.2. This reflects a platform update rather than a change to the study details or other user-facing content.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now explicitly indicates that recruitment is closed and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study). A formatting update replaces the Interventions heading from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.